| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 871,1 k € | +38.6% | 628,7 k € | -3.9% | 654,3 k € | +30.5% | 501,2 k € | +21.9% | 411,1 k € | +6.4% | 386,4 k € | -21.4% | 491,6 k € | +20.2% | 409,0 k € | -18.1% | 499,7 k € | -5.8% | 530,4 k € | +22.8% | 432,0 k € | -32.0% | 635,0 k € | +116.5% | 293,3 k € | +43.7% | 204,1 k € | -55.2% | 455,6 k € | +30.6% | 348,8 k € | -40.8% | 589,4 k € | +50.8% | 390,9 k € | +26.9% | 308,0 k € | |
| EBITDA | 865,0 k € | +40.9% | 614,0 k € | -5.1% | 647,2 k € | +31.4% | 492,6 k € | +24.6% | 395,2 k € | +5.4% | 375,1 k € | -22.2% | 482,4 k € | +20.9% | 399,0 k € | +149.5% | 159,9 k € | -69.4% | 523,1 k € | +23.3% | 424,3 k € | -31.1% | 616,0 k € | +182.6% | 218,0 k € | +20.6% | 180,7 k € | -57.7% | 427,5 k € | +31.7% | 324,5 k € | -42.8% | 567,7 k € | +47.1% | 385,9 k € | +32.2% | 291,8 k € | |
| Operating profit | 756,9 k € | +46.4% | 517,2 k € | -7.7% | 560,1 k € | +29.3% | 433,1 k € | +38.9% | 311,8 k € | +7.4% | 290,4 k € | -26.7% | 396,0 k € | +25.7% | 315,0 k € | +319.4% | 75,1 k € | -74.4% | 293,7 k € | -14.2% | 342,5 k € | -35.9% | 534,0 k € | +236.5% | 158,7 k € | +39.2% | 114,0 k € | -68.3% | 359,8 k € | +35.3% | 265,9 k € | -47.4% | 505,6 k € | +78.5% | 283,3 k € | +38.9% | 204,0 k € | |
| Profit/loss | 507,7 k € | +45.8% | 348,3 k € | -6.8% | 373,8 k € | +31.1% | 285,0 k € | +60.7% | 177,3 k € | +18.0% | 150,3 k € | -35.5% | 233,0 k € | +43.4% | 162,4 k € | +1046.4% | 14,2 k € | -75.9% | 58,7 k € | -66.5% | 175,4 k € | -52.7% | 370,6 k € | +514994.3% | 71,9 € | +100.3% | -23,2 k € | -117.9% | 130,0 k € | -14.5% | 152,1 k € | -52.5% | 320,3 k € | +70.5% | 187,9 k € | +38.4% | 135,8 k € | |
| Equity | 2,4 M € | +6.5% | 2,2 M € | +18.7% | 1,9 M € | +25.1% | 1,5 M € | +23.7% | 1,2 M € | +17.3% | 1,0 M € | +17.4% | 875,2 k € | -23.0% | 1,1 M € | +16.7% | 973,6 k € | +1.5% | 959,4 k € | +6.5% | 900,7 k € | +24.2% | 725,3 k € | +28.8% | 562,9 k € | +0.0% | 562,9 k € | -31.5% | 821,4 k € | +18.8% | 691,3 k € | +28.2% | 539,2 k € | -12.9% | 618,9 k € | +43.6% | 430,9 k € | |
| Total assets | 3,0 M € | -5.4% | 3,2 M € | +9.6% | 2,9 M € | +10.1% | 2,6 M € | -2.0% | 2,7 M € | -2.6% | 2,8 M € | -1.8% | 2,8 M € | +1.4% | 2,8 M € | -2.7% | 2,8 M € | -9.5% | 3,1 M € | +36.2% | 2,3 M € | -3.4% | 2,4 M € | +17.8% | 2,0 M € | +25.6% | 1,6 M € | -18.5% | 2,0 M € | +5.2% | 1,9 M € | -12.3% | 2,1 M € | +12.2% | 1,9 M € | +144.1% | 784,3 k € | |
| Cash | 38,5 k € | +139.7% | 16,1 k € | -58.1% | 38,3 k € | +114.7% | 17,8 k € | +237.6% | 5,3 k € | — | 23,9 k € | — | 38,0 k € | +438.8% | 7,0 k € | -91.0% | 78,4 k € | +14.7% | 68,4 k € | -28.8% | 96,1 k € | +184.7% | 33,7 k € | +142.8% | 13,9 k € | -80.8% | 72,4 k € | +102.7% | 35,7 k € | -2.2% | 36,5 k € | -22.5% | 47,1 k € | |||||
| Debts | 642,3 k € | -32.9% | 957,2 k € | -6.9% | 1,0 M € | -9.5% | 1,1 M € | -23.0% | 1,5 M € | -14.4% | 1,7 M € | -10.6% | 1,9 M € | +18.4% | 1,6 M € | -12.8% | 1,9 M € | -14.4% | 2,2 M € | +55.2% | 1,4 M € | -15.4% | 1,7 M € | +13.5% | 1,5 M € | +39.2% | 1,1 M € | -9.3% | 1,2 M € | -2.6% | 1,2 M € | -25.9% | 1,6 M € | +24.1% | 1,3 M € | +271.4% | 348,8 k € | |
| Staff | — | — | — | — | — | — | — | — | — | — | 0,1 | 0,1 | — | 0,5 | 0,5 | 0,5 | 0,5 | — | 0,3 | |||||||||||||||||||
Private limited company · Herentals · incorporated on 29/09/1997
Private limited company profitable and well capitalised. Cash position rising (+139.7%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR. B. DOLFIJN is a Private limited company incorporated in 1997. Its main activity is: Specialist medical practice activities. Its registered office is in Herentals.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette